Jiangsu Hualan New Pharmaceutical Material Co. Ltd.Controlling shareholder pledges 3.9 million shares, indicating potential financial strain or risk of forced selling.

Hualan Co.'s controlling shareholder, Jiangyin Hualan Electromechanical Technology Co., Ltd., has pledged 3.9 million shares, representing 8.07% of its holdings and 1.83% of the company's total share capital. As of the announcement date, Jiangyin Hualan Electromechanical has cumulatively pledged 6.11 million shares, accounting for 12.65% of its holdings and 2.87% of the company's total share capital. In the first quarter of 2026, Hualan Co. achieved revenue of 130 million yuan and a net profit attributable to the parent company of 610,000 yuan.
Jiangsu Hualan New Pharmaceutical Material Co. Ltd.Controlling shareholder pledges 3.9 million shares, indicating potential financial strain or risk of forced selling.
As the controlling shareholder, its pledge of shares signals possible liquidity issues or financial pressure.